Skip to the content
Altai Oncology - Softwarelogo darklogo light
  • Products
    • Protocol Library
    • Hematology & Oncology App
    • Oncology Software for Windows
    • Chemo Planner for Windows
  • Library
  • Articles
  • Patient Education
  • F.A.Q.
  • Contact Us
Altai Oncology - Softwarelogo darklogo light
New Protocol: Perioperative Serplulimab with Chemotherapy for PD-L1 Positive Gastric Cancer
Altai Protocol Library

New Protocol: Perioperative Serplulimab with Chemotherapy for PD-L1 Positive Gastric Cancer

U. Darda Bayraktar, MD
2026-06-17
New Protocol: Sacituzumab Tirumotecan with Pembrolizumab for PD-L1 Positive Advanced NSCLC
Altai Protocol Library

New Protocol: Sacituzumab Tirumotecan with Pembrolizumab for PD-L1 Positive Advanced NSCLC

U. Darda Bayraktar, MD
2026-06-17
New Reference: Perioperative Pembrolizumab for MSI-H/dMMR Colorectal Cancer
Altai Protocol Library

New Reference: Perioperative Pembrolizumab for MSI-H/dMMR Colorectal Cancer

U. Darda Bayraktar, MD
2026-06-17
New Reference: Ivonescimab with Chemotherapy for Advanced Squamous NSCLC
Altai Protocol Library

New Reference: Ivonescimab with Chemotherapy for Advanced Squamous NSCLC

U. Darda Bayraktar, MD
2026-06-17
New Indication: Duvelisib for Peripheral T-Cell Lymphoma
Altai Protocol Library

New Indication: Duvelisib for Peripheral T-Cell Lymphoma

U. Darda Bayraktar, MD
2026-06-17
New Protocol: Datopotamab deruxtecan with Durvalumab for Triple-Negative Breast Cancer
Altai Protocol Library

New Protocol: Datopotamab deruxtecan with Durvalumab for Triple-Negative Breast Cancer

U. Darda Bayraktar, MD
2026-06-17
New Drug: Daraxonrasib for Previously Treated Pancreatic Cancer
Altai Protocol Library

New Drug: Daraxonrasib for Previously Treated Pancreatic Cancer

U. Darda Bayraktar, MD
2026-06-17
New Reference: Carboplatin Addition to (Neo)Adjuvant Therapy in Triple-Negative Breast Cancer
Altai Protocol Library

New Reference: Carboplatin Addition to (Neo)Adjuvant Therapy in Triple-Negative Breast Cancer

U. Darda Bayraktar, MD
2026-06-17
New Reference: Perioperative Apalutamide in High-Risk Localized Prostate Cancer
Altai Protocol Library

New Reference: Perioperative Apalutamide in High-Risk Localized Prostate Cancer

U. Darda Bayraktar, MD
2026-06-17
New Protocol: Zanidatamab with Chemotherapy for Metastatic HER2-Positive Gastroesophageal Cancer
Altai Protocol Library

New Protocol: Zanidatamab with Chemotherapy for Metastatic HER2-Positive Gastroesophageal Cancer

U. Darda Bayraktar, MD
2026-06-15

Posts pagination

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35
  • Library
  • F.A.Q.
  • Contact Us

Privacy Policy

Altai, Inc (USA)

30 N Gould St, Ste 6801

Sheridan, WY, 82801, USA

Phone: +1 (978) 393 0042

Altay Tıp Sağlık Yazılım AŞ (Türkiye)

Mutlukent Mah Manuk Bey Sk No: 4

Çankaya, Ankara, 06800, Türkiye

Phone: +90 (312) 911 5735

Our Terms & Privacy Policy

Copyright - 2024 - Altai Inc - All rights reserved

Back to top Drag
  • Products
    • Protocol Library
    • Hematology & Oncology App
    • Oncology Software for Windows
    • Chemo Planner for Windows
  • Library
  • Articles
  • Patient Education
  • F.A.Q.
  • Contact Us

jghghjghjghhgj